Whan In Pharm Co.,Ltd. (KRX:016580)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,900
-80 (-0.67%)
Last updated: Jun 23, 2025
-20.13%
Market Cap 184.58B
Revenue (ttm) 258.19B
Net Income (ttm) 19.43B
Shares Out 15.27M
EPS (ttm) 1,272.45
PE Ratio 9.50
Forward PE 7.67
Dividend 300.00 (2.51%)
Ex-Dividend Date Dec 27, 2024
Volume 17,119
Average Volume 20,584
Open 11,960
Previous Close 11,980
Day's Range 11,750 - 11,960
52-Week Range 10,530 - 15,900
Beta 0.31
RSI 60.17
Earnings Date Jul 30, 2025

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceuticals products in South Korea. The company offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1978
Employees 611
Stock Exchange Korea Stock Exchange
Ticker Symbol 016580
Full Company Profile

Financial Performance

In 2024, Whan In Pharm's revenue was 259.60 billion, an increase of 12.68% compared to the previous year's 230.39 billion. Earnings were 23.38 billion, a decrease of -21.47%.

Financial Statements

News

There is no news available yet.